NeurologyLive, August 2019 – Akcea Therapeutics and Ambry Genetics have expanded its hATTR Compass partnership program that provides support and resources to patients, caregivers, family members and healthcare professionals. Hear from a physician who has used hATTR Compass in their own practice why the program matters.